Transfersomes: Novel vesicular carriers for enhanced transdermal drug delivery of Candesartan cilexetil
Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2014, Vol 2, Issue 5
Abstract
The aim of this research activity is to formulate Soyalecithin based transfersomal nanoparticles for percutaneous administration of Candesartan cilexetil for better management against cardiovascular diseases. The I.R peaks obtained for the physical mixture of Candesartan cilexetil was mostly identical with the pure sample of Candesartan cilexetil indicating their compatibility. Candesartan cilexetil transfersomes were formulated by employing thin film hydration followed by high speed homogenization technique. Drug entrapment efficiency of optimized formulation “F3” was found to be 50.72%. In-vitro diffusion studies of all the formulations revealed that the Candesartan cilexetil transfersomes followed first order kinetics, ascertaining Peppas mechanism. Application of Korsmeyer-Peppas equation to the data of the formulations revealed that mechanism of Candesartan cilexetil transfersomes was governed by predominant Non-Fickian diffusion (0.5>n<0.85). Based on the satisfied release studies of all the formulations, F3 was confined to be the optimized formulation. The particle size of the formulation F3 was found to be 194.4nm indicating that the formulation was well within the nanosomal range. The zeta potential value of the formulation F3 was found to be -27.6mv indicating high negative surface charge leading to higher stability. SEM analysis reports revealed that the transfersomal images confined to the nanosomal range. Based on the results, the formulation F3 was considered as the better formulation (% Entrapment efficiency- 50.72%, Zeta Potential- 27.6mv, % Drug diffusion -58±2.4%) for the effective management of cardio vascular diseases.
Authors and Affiliations
Kalyani . V, M. Kishore Babu
Keywords
Related Articles
- EP ID EP33247
- DOI -
- Views 295
- Downloads 0
Comparative in-vitro dissolution study of five brands of Diclofenac sodium delayed release tablets in QbD environment
Diclofenac sodium tablets are available as delayed release tablets in the market. Delayed release tablets are typically produced by coating the tablet with enteric coating polymers. These polymers provide the resistanc...
Preparation and evaluation of pulsatile drug delivery of Metaprolol succinate
In the present study, an effort was made to develop the pulsatile drug delivery of Metaprolol succinate to the colon. A time delayed capsule was prepared by sealing the microspheres inside the insoluble hard gelatin ca...
In vitro cytotoxic studies of various formulations of Indian medicinal plants
The present study explores the cytotoxic activity of various polyherbal formulations prepared from the combination of chloroform extracts of leaves of Tevetia peruviana, Waltheria indica and Toddalia asiatica. Polyherb...
Comparative In- vitro evaluation of commercially available sustained release Aceclofenac tablets
Purpose: The objective of the study was to determine the difference between commercial available Aceclofenac sustained release tablets. Methods: Four commercially available tablets Hifenac SR(A), Acceclowoc SR(B), Acel...
Formulation and in-vitro evaluation of Aceclofenac loaded topical Emulgel
Gels are a relatively newer class of dosage form created by entrapment of large amounts of aqueous or hydro alcoholic liquid in a network of colloidal solid particles. Gel formulations generally provide faster drug rele...